We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BMYB34 market cap is 722.85B. The company's latest EPS is USD 3.9440 and P/E is 14.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.97B | 11.48B | 11.87B | 12.2B | 11.89B |
| Operating Income | 1.45B | 1.64B | -11.67B | 1.33B | 1.73B |
| Net Income | 1.93B | 1.76B | -11.91B | 1.68B | 1.21B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 26.15B | 42.52B | 46.39B | 46.16B | 45.01B |
| Operating Income | 5.8B | 3.12B | 7.87B | 7.24B | 6.91B |
| Net Income | 3.44B | -9.02B | 6.99B | 6.33B | 8.03B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 91.26B | 95.16B | 99.03B | 94.65B | 93.67B |
| Total Liabilities | 62.2B | 65.67B | 82.48B | 77.58B | 76.47B |
| Total Equity | 29.06B | 29.49B | 16.55B | 17.07B | 17.2B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 129.94B | 118.48B | 109.31B | 96.82B | 95.16B |
| Total Liabilities | 78.25B | 80.6B | 73.31B | 65.7B | 65.67B |
| Total Equity | 51.7B | 37.88B | 36.01B | 31.12B | 29.49B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.61B | 13.86B | 2.83B | 5.16B | 10.75B |
| Investing | -949M | -2.3B | -19.62B | -20.94B | -21.16B |
| Financing | -10.38B | -9.42B | 14.64B | 10.62B | 6.77B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.07B | 14.05B | 16.21B | 13.07B | 13.86B |
| Investing | -9.77B | -10.86B | -538M | -1.06B | -2.3B |
| Financing | 7.62B | -1.15B | -16.22B | -16.96B | -9.42B |
| Market Cap | 722.85B |
| Price to Earnings Ratio | 14.66 |
| Price to Sales Ratio | 2.61 |
| Price to Cash Ratio | 10.26 |
| Price to Book Ratio | 3.99 |
| Dividend Yield | 4.21% |
| Shares Outstanding | 2.03B |
| Average Volume (1 week) | 23 |
| Average Volume (1 Month) | 228 |
| 52 Week Change | 42.24% |
| 52 Week High | 363.51 |
| 52 Week Low | 203.10 |
| Spread (Intraday) | 0.87 (0.24%) |
| Company Name | Bristol-Myers Squibb Co. |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bms.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
